SG11202001516QA - Compositions and methods for modulating hair growth - Google Patents

Compositions and methods for modulating hair growth

Info

Publication number
SG11202001516QA
SG11202001516QA SG11202001516QA SG11202001516QA SG11202001516QA SG 11202001516Q A SG11202001516Q A SG 11202001516QA SG 11202001516Q A SG11202001516Q A SG 11202001516QA SG 11202001516Q A SG11202001516Q A SG 11202001516QA SG 11202001516Q A SG11202001516Q A SG 11202001516QA
Authority
SG
Singapore
Prior art keywords
compositions
methods
hair growth
modulating hair
modulating
Prior art date
Application number
SG11202001516QA
Other languages
English (en)
Inventor
William Lowry
Heather Christofk
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SG11202001516QA publication Critical patent/SG11202001516QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pain & Pain Management (AREA)
SG11202001516QA 2017-09-29 2018-09-28 Compositions and methods for modulating hair growth SG11202001516QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762566031P 2017-09-29 2017-09-29
PCT/US2018/053351 WO2019067860A1 (en) 2017-09-29 2018-09-28 COMPOSITIONS AND METHODS FOR MODULATION OF HAIR GROWTH

Publications (1)

Publication Number Publication Date
SG11202001516QA true SG11202001516QA (en) 2020-03-30

Family

ID=65903207

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202109849S SG10202109849SA (en) 2017-09-29 2018-09-28 Compositions and methods for modulating hair growth
SG11202001516QA SG11202001516QA (en) 2017-09-29 2018-09-28 Compositions and methods for modulating hair growth

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202109849S SG10202109849SA (en) 2017-09-29 2018-09-28 Compositions and methods for modulating hair growth

Country Status (16)

Country Link
US (1) US20200253917A1 (pt)
EP (1) EP3687528A4 (pt)
JP (1) JP2020536048A (pt)
KR (1) KR20200062242A (pt)
CN (1) CN111295188A (pt)
AU (1) AU2018339064A1 (pt)
BR (1) BR112020003349A2 (pt)
CA (1) CA3077359A1 (pt)
CL (1) CL2020000676A1 (pt)
EA (1) EA202090855A1 (pt)
IL (1) IL272827A (pt)
MX (1) MX2020002389A (pt)
PE (1) PE20210464A1 (pt)
PH (1) PH12020500300A1 (pt)
SG (2) SG10202109849SA (pt)
WO (1) WO2019067860A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA038943B1 (ru) 2017-02-24 2021-11-12 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Применение ингибитора mpc1 для ускорения или восстановления роста волос
KR20240033119A (ko) 2017-06-30 2024-03-12 더 리전트 오브 더 유니버시티 오브 캘리포니아 모발 성장을 조절하기 위한 조성물 및 방법
KR102561912B1 (ko) * 2021-04-09 2023-07-31 차의과학대학교 산학협력단 세팔로틴 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 탈모방지 또는 발모촉진용 조성물
CN113694063A (zh) * 2021-08-31 2021-11-26 佛山市第一人民医院(中山大学附属佛山医院) 一种组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014221D0 (en) * 1990-06-26 1990-08-15 Janssen Pharmaceutica Nv Method of treating alopecia
WO2001062237A2 (en) * 2000-02-23 2001-08-30 Orentreich Foundation For The Advancement Of Science, Inc. Compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
CA2580642C (en) * 2004-09-17 2014-09-02 Biomas, Ltd. Novel tellurium compounds and their use as immunomodulators
CA2611577A1 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US8343962B2 (en) * 2006-03-06 2013-01-01 Nuvo Research Inc. Topical formulation
US9308181B2 (en) * 2006-03-06 2016-04-12 Nuvo Research Inc. Topical formulations, systems and methods
WO2009030257A1 (en) * 2007-09-05 2009-03-12 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Methods and compounds for treating diseases caused by reactive oxygen species
WO2012078649A1 (en) * 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
CN106880693A (zh) * 2017-03-22 2017-06-23 广州国草夏方生物科技有限公司 一种治疗脂溢性脱发的生发液组合物及其制备方法

Also Published As

Publication number Publication date
JP2020536048A (ja) 2020-12-10
IL272827A (en) 2020-04-30
BR112020003349A2 (pt) 2020-08-18
AU2018339064A1 (en) 2020-02-27
MX2020002389A (es) 2020-10-01
CA3077359A1 (en) 2019-04-04
EP3687528A4 (en) 2021-07-21
KR20200062242A (ko) 2020-06-03
CL2020000676A1 (es) 2020-09-25
PH12020500300A1 (en) 2020-11-09
WO2019067860A1 (en) 2019-04-04
EP3687528A1 (en) 2020-08-05
PE20210464A1 (es) 2021-03-08
US20200253917A1 (en) 2020-08-13
SG10202109849SA (en) 2021-10-28
CN111295188A (zh) 2020-06-16
EA202090855A1 (ru) 2020-06-26

Similar Documents

Publication Publication Date Title
IL271443A (en) Preparations and methods for regulating hair growth
ZA201805064B (en) Hair growth composition and method
IL255462A (en) Methods and preparations to promote hair growth
EP3139957A4 (en) Compositions and methods for growth factor modulation
IL284397A (en) Preparations and methods for regulating hair growth
IL272827A (en) Preparations and methods for regulating hair growth
IL268275A (en) An injectable composition for preventing hair loss or encouraging hair growth
IL249696A0 (en) Methods and preparations for modulating hair growth
EP3349749A4 (en) COMPOSITIONS AND METHODS FOR MODULATING FMR1 EXPRESSION
EP3484498A4 (en) HAIR GROWTH COMPOUNDS AND METHODS.
EP3402575A4 (en) METHODS AND COMPOSITIONS FOR TREATING DAMAGED HAIR
IL268345A (en) Preparations and methods for promoting hair growth with mpc1 inhibitors
PL3062797T3 (pl) Kompozycje zmniejszające wypadanie włosów i/lub zwiększające odrastanie włosów
HK1243356A1 (zh) 用於促進毛髮生長或毛髮修複和用於抗炎的組合物
EP3662891C0 (en) COMPOSITION FOR PREVENTING HAIR LOSS OR FOR STIMULATING HAIR GROWTH
HK1254449A1 (zh) 含有大豆皂苷的生長毛髮和/或修復毛髮促進用組合物
GB2580226B (en) Formulations for hair growth
EP3664773A4 (en) HAIR TREATMENT COMPOSITIONS AND PROCEDURES
EP3090727B8 (en) Hair growth composition
PT3638198T (pt) Composição para prevenir a queda do cabelo e promover o seu crescimento
PL3494955T3 (pl) Kompozycja kosmetyczna wspomagająca wzrost włosów
EP3328406A4 (en) COMPOSITIONS DERIVED FROM MULATEIRO AND THEIR USE FOR PREVENTING THE FALL OF HAIR AND PROMOTING HAIR GROWTH
EP3452174A4 (en) HAIR RELAXATION COMPOSITIONS AND METHOD
EP3111920A4 (en) Composition for promoting hair growth and/or hair restoration containing sulfa agent and chitosan agent
AU2017902782A0 (en) Hair Growth Stimulator